Efficacy and Safety of Cefotaxime in Combination with Metronidazole for Empirical Treatment of Brain Abscess in Clinical Practice: A Retrospective Study of 66 Consecutive Cases
Authors:
- 11 December 2003
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 23 (1) , 7-14
Abstract
Sixty-six consecutive patients with brain abscesses referred to a department of neurosurgery during a 10-year period and treated with cefotaxime were studied retrospectively by means of a prospectively designed protocol whose main areas of emphasis were duration of antibiotic treatment, sterilization rate, clinical outcome in relation to prognostic factors, and side effects. Sixty-two of these patients were treated additionally with metronidazole, and surgery was performed in 53 patients. Mental status was altered in 33 patients, 11 of whom were comatose. Rupture of the abscess into the ventricles occurred in eight patients. Death was attributable to brain abscess formation in three patients (4.5%). Forty-six percent of the surviving patients recovered without any neurological deficits. Reversible adverse reactions, which occurred in 38 patients, were the most common reason for withdrawal of cefotaxime. In 76% of these cases, there was a significant improvement before the onset of the adverse reaction. The median duration of parenteral antibiotic treatment was 36, 41, 22, and 46 days in patients treated with excision, aspiration, evacuation of subdural empyema, and antibiotics alone, respectively. Taking prognostic factors into consideration, mortality attributable to brain abscess was lower than previously reported. This finding, along with the abscess sterilization results, indicates that cefotaxime in combination with metronidazole is a highly effective treatment but is associated with a high frequency of reversible side effects. The results indicate that a shorter duration of treatment should be investigated.Keywords
This publication has 13 references indexed in Scilit:
- Management of Brain Abscesses with Sequential Intravenous/Oral Antibiotic TherapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- The rational use of antibiotics in the treatment of brain abscessBritish Journal Of Neurosurgery, 2000
- Incidence of β-Lactam–Induced Delayed Hypersensitivity and Neutropenia During Treatment of Infective EndocarditisArchives of internal medicine (1960), 1999
- Brain AbscessClinical Infectious Diseases, 1997
- Treatment of Brain Abscess with Cefotaxime and Metronidazole: Prospective Study on 15 Consecutive PatientsClinical Infectious Diseases, 1993
- Bacterial Brain Abscesses: Factors Influencing Mortality and SequelaeClinical Infectious Diseases, 1992
- Penetration of cefotaxime and desacetylcefotaxime into brain abscesses in humansAntimicrobial Agents and Chemotherapy, 1991
- Intracranial Abscesses in Adults: An Analysis of 54 Consecutive CasesScandinavian Journal of Infectious Diseases, 1988
- Brain abscess. A study of 45 consecutive cases.1986
- Penetration of brain abscess by systemically administered antibioticsJournal of Neurosurgery, 1973